NCT06406478

Brief Summary

The goal of this clinical trial is to explore how working a 4-day schedule impacts nurse manager wellbeing and job performance. The main questions it aims to answer are:

  • Do those working 4-days have improved wellbeing with reduced levels of burnout and work/family conflict when compared to those in the control group?
  • Do levels of sleep, heart rate variability, and physical activity significantly differ between those working the 4-day schedule change and those in the control group?
  • Are nurse manager satisfaction, patient satisfaction, and patient quality outcomes different among those working the 4-day schedule change and those in the control group? Researchers will compare those working the 4-day schedule change to those working the standard 5-day schedule to determine causality between the intervention and the outcomes. Participants will:
  • Complete an initial visit to learn about the study.
  • Begin wearing an OURA ring, which will collect data on physical activity, sleep, and heart rate variability. They will need to download the Oura Ring app on their phone and log in weekly to sync data so that the researchers may access it.
  • Complete the first survey on the online REDCap platform (baseline).
  • Begin the work schedule that was assigned to them.
  • Clock in and out of work each shift.
  • Take the follow-up survey online (month 3).
  • Take the final survey online (month 6).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 9, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

November 14, 2024

Status Verified

May 1, 2024

Enrollment Period

2 months

First QC Date

April 10, 2024

Last Update Submit

November 12, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • work family conflict

    Work family conflict will be measured with the Work-Family and Family-Work Conflict Scale + Work-Life Balance scale with 11 items. Work-Family Conflict is determined with a mean of score of responses for items 1 through 5; higher scores reflect more work-family conflict. Family-Work Conflict is determined with the mean of score of responses for items 6 through 10; higher scores reflect more family-work conflict. Work-Life Balance: Item score.

    0, 3, and 6 months

  • Burnout

    Burnout will be measured with the Oldenburg Burnout Inventory with 16 items. Disengagement in burnout is the sum of items: 1, 3(Reverse), 6(Reverse), 7, 9(Reverse), 11(Reverse), 13, and 15. Exhaustion is the sum of items: 2(Reverse), 4(Reverse), 5, 8(Reverse), 10, 12(Reverse), 14, and 16. Full Burnout is the sum of the two scales: Disengagement and exhaustion.

    0, 3, and 6 months

Secondary Outcomes (11)

  • Hospital rate of Central Line-associated Bloodstream Infection (CLABSI)

    6 months

  • Hospital rate of center-association urinary tract infections (CAUTI)

    6 months

  • Hospital rate of falls

    6 months

  • Hospital rate of hospital acquired pressure injuries

    6 months

  • Nurse manager satisfaction as assessed by the National Database of Nursing Quality Indicators (NDNQI)

    6 months

  • +6 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

The intervention group will begin working only four days a week as a schedule change.

Behavioral: Schedule Change

Control Group

ACTIVE COMPARATOR

The control group will continue to work five days per week, receiving standard practice for the schedule policies at the participating study sites.

Behavioral: No Schedule Change

Interventions

Schedule ChangeBEHAVIORAL

This 4-day workweek is defined by any 4 ten hour shifts between Sunday and Saturday. It will be up to the discretion of participants in the intervention group to coordinate which 4 days they work. The 4 days will most likely be weekdays, but some participants may work weekends. If participants do any work from home, they will clock in remotely to account for the time.

Intervention Group

The control group will continue to work five days per week, receiving standard practice for the schedule policies at the participating study sites.

Control Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • Registered nurse
  • Currently employed as a full-time nurse manager
  • Having a span of control greater than 40 Full Time Equivalent (FTE) Direct Reports
  • Currently working at either Ronald Regan UCLA Medical Center or UCLA Medical Center Santa Monica
  • In the acute care setting

You may not qualify if:

  • Those working in ambulatory care settings
  • Nurse leaders with less than 30 FTE's
  • Working part time
  • Working a schedule less than 5 days a week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ronald Reagan UCLA Medical Center

Los Angeles, California, 90095, United States

RECRUITING

UCLA Health, Santa Monica

Santa Monica, California, 90404, United States

RECRUITING

Study Officials

  • Jian Li, MD, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elizabeth G Keller, PhD

CONTACT

Jian Li, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking will occur in this study, as the groups will be aware of which schedule they are working, and the researchers will be examining differences between intervention and control groups.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Participants will be stratified by study site and race, and then randomized into either the control or intervention group. The allocation sequences will be generated by a research team member using a random number table assigning groups 1:1, with equal numbers of participants in each intervention and control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 10, 2024

First Posted

May 9, 2024

Study Start

January 1, 2025

Primary Completion

March 1, 2025

Study Completion

September 1, 2025

Last Updated

November 14, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations